Effects of Nerve Blocks on Pain After Caesarean Section and Postpartum Depression
Launched by KAHRAMANMARAS SUTCU IMAM UNIVERSITY · Jan 15, 2024
Trial Information
Current as of July 04, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Having a good mental status,
- • 2. Those aged ≥18 years,
- • 3. Term pregnant (gestational age ≥ 36 weeks),
- • 4. American Society of Anesthesiologists class II-III,
- • 5. Patients who underwent cesarean section with spinal anesthesia will be included.
- Exclusion Criteria:
- • 1. Having labor at term or obstetric emergency,
- • 2. Having a twin pregnancy,
- • 3. Having a diagnosed psychiatric disorder/using psychiatric medication,
- • 4. Those who are allergic to local anesthetics and/or drugs used in the study,
- • 5. The patient-controlled anesthesia device is out of use for any reason within the first 24 hours postoperatively,
- • 6. Having peripheral neuropathy or neuromuscular disease,
- • 7. Patients using anticoagulant drugs that will prevent regional anesthesia will be excluded from the study.
About Kahramanmaras Sutcu Imam University
Kahramanmaras Sutcu Imam University is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university harnesses the expertise of its faculty and researchers to conduct rigorous studies that address critical health challenges. Committed to ethical standards and scientific integrity, Kahramanmaras Sutcu Imam University aims to contribute valuable insights to the medical community, ultimately enhancing patient care and treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kahramanmaraş, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported